![]() | |
![]() | |
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.037.767![]() |
Chemical and physical data | |
Formula | C17H18N2 |
Molar mass | 250.345 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Amfetaminil (also known asamphetaminil,N-cyanobenzylamphetamine,[1] andAN-1; brand nameAponeuron) is astimulant drug derived fromamphetamine, which was developed in the 1970s and used for the treatment ofobesity,[2]ADHD,[3][4] andnarcolepsy.[5] It has largely been withdrawn from clinical use following problems withabuse.[6] The drug is aprodrug toamphetamine.[7][8]
Amfetaminil is a molecule with two stereogenic centers. Thus, four different stereoisomers exist:
Schiff base formation between amphetamine (1) and benzaldehyde (2) gives benzalamphetamine [2980-02-1] (3). Nucleophilic attack of cyanide anion on the imine (c.f. Strecker reaction) gives amfetaminil (4). Finally, reaction with nitrous acid gives (5). The rearrangement to aSydnone then occurs to giveCID:88166659 (6).Feprosidnine is sans the phenyl group.